Parents struggle to monitor teens’ caffeine intake, national poll reveals

FHS
May 20, 2024
5:53 pm

A quarter of parents report that caffeine is basically part of their teen’s daily life, according to a national poll.

Tepotinib Gains Full Approval for Metastatic NSCLC

The FDA transitioned the small-molecule inhibitor tepotinib (Tepmetko) from accelerated to full approval for metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping

February 17, 2024

FDA Advisory Panel Generally Pleased With Pulse Oximetry Clinical Trial Proposal

An FDA advisory committee gave generally high marks to the agency’s latest effort to improve the accuracy of pulse oximeters when used in darker-skinned patients,

February 4, 2024

ACTUS-101 by Asklepios BioPharmaceutical for Pompe Disease: Likelihood of Approval

ACTUS-101 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Pompe Disease.

December 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.